South and Central America accounts for 2.8% share of global clinical trial activity in 2020

Middle East and Africa accounts for 11.2% share of global clinical trial activity in 2020

Europe accounts for 19.3% share of global clinical trial activity in 2020

OCT West Coast: how can decentralisation help optimise rare disease trials?

Throughout the Covid-19 pandemic, decentralised clinical trials (DCTs) have been imperative for the continuation of...

OCT West Coast: IQVIA’s Nagaraja Srivatsan talks decentralised trials and the future of clinical research

Decentralised clinical trials, and the digital technologies that facilitate them, have been a lifeline for...

Congestive Heart Failure accounts for 12.9% share of global Cardiovascular clinical trial activity in 2020

Coronary Artery Disease accounts for 12.5% share of global Cardiovascular clinical trial activity in 2020

Hope remains that Roche’s prasinezumab can overcome recent string of failures in Parkinson’s disease

North America accounts for 22.5% share of global clinical trial activity in 2020

Altasciences completes acquisition of US-based CRO WCCT Global

Mid-size CRO/CDMO Altasciences has acquired early-stage clinical research organisation (CRO) WCCT Global.